Parallax Volatility Advisers
GENE

Parallax Volatility Advisers’s Genetic Technologies Ltd. GENE Stock Holding History

Parallax Volatility Advisers’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-264
Closed -$5K – 3794
2018
Q2 		$5K Hold
264
– – ﹤0.01% 1830
2018
Q1 		$5K Hold
264
– – ﹤0.01% 1943
2017
Q4 		$6K Buy
+264
New +$4.96K ﹤0.01% 3829

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
BA
Ballew Advisors Jackson, Mississippi $194M AUM 20.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parallax Volatility Advisers's GENE Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of Genetic Technologies Ltd. (GENE) in Q3 2018, closing a stake of 264 shares — an estimated $5K sold.

Parallax Volatility Advisers first reported a position in GENE in Q4 2017 and held it in 3 quarters. The position peaked at $6K in Q4 2017. 14 funds tracked by Wall St. Rank hold GENE as of Q3 2018.

  • Parallax Volatility Advisers reported no remaining Genetic Technologies Ltd. position as of Q3 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 264 Genetic Technologies Ltd. shares in Q3 2018, an estimated $5K.
  • Parallax Volatility Advisers first reported a position in Genetic Technologies Ltd. in Q4 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's Genetic Technologies Ltd. position peaked at $6K in Q4 2017.
  • 14 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.